The clinical correlation between the levels of PDCD11 and most of these G1/S‐related C‐MYC targets was further confirmed through TCGA‐based Pearson analysis using Gene Expression Profiling Interactive Analysis 2 (GEPIA2)[19] (Figure S5, Supporting Information), suggesting that PDCD11 promotes tumor progression by modulating C‐MYC signaling. The gene discussed is PDCD11; the disease is neoplasm.